On the other hand, median NfL levels were significantly elevated in patients with stage IV NSCLC and IMD (34 pg/mL) compared to patients with stage I NSCLC (p = 0.002) and stage IV NSCLC without brain involvement (p = 0.015) [19]. The gene discussed is NEFL; the disease is non-small cell lung carcinoma.